Core Points - The company, Heptagon Pharmaceuticals-B, repurchased 400,000 shares on November 7 at a price range of HKD 11.980 to HKD 12.700, totaling HKD 4.9715 million [2] - The stock closed at HKD 12.570 on the same day, reflecting a decline of 3.16%, with a total trading volume of HKD 130 million [2] - Since November 6, the company has conducted share buybacks for two consecutive days, totaling 500,000 shares and an aggregate amount of HKD 6.2497 million, with a cumulative decline of 0.87% in stock price during this period [2] Buyback Summary - The company has executed a total of 59 buybacks this year, amounting to 23.893 million shares and a total expenditure of HKD 170 million [3] - Detailed buyback transactions include: - November 7: 40,000 shares at a maximum price of HKD 12.700 and a minimum of HKD 11.980, totaling HKD 497.15 thousand [3] - November 6: 10,000 shares at a maximum price of HKD 12.990 and a minimum of HKD 12.610, totaling HKD 127.82 thousand [3] - November 4: 20,000 shares at a maximum price of HKD 13.220 and a minimum of HKD 12.770, totaling HKD 258.49 thousand [3]
和铂医药-B(02142.HK)11月7日回购497.15万港元，已连续2日回购